🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Adrienne L. Lehnert

University of Washington

ORCID: 0000-0001-5043-6820

Physics and AstronomyMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma”.

Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma

EJNMMI Research(2024)10.1186/s13550-024-01134-1

N/A

0.269DataRank · unranked

5 citations

Adrienne L. Lehnert, Donald K. Hamlin, Kevin P. Labadie, Kristin E. Goodsell, Yong-Jun Liu +5 more

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma

Scientific Reports(2021)10.1038/s41598-021-82172-w

N/A

0DataRank · unranked

22 citations

Andrew D. Ludwig, Adrienne L. Lehnert, Donald K. Hamlin, Aimee L. Kenoyer, Kevin M. Sullivan +10 more

Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma

EJNMMI Research(2023)10.1186/s13550-023-00980-9

N/A

0DataRank · unranked

10 citations

Adrienne L. Lehnert, Aimee L. Kenoyer, Donald K. Hamlin, Andrew D. Ludwig, Alan F. Utria +9 more

Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma

Research Square(2023)10.21203/rs.3.rs-2533949/v1

N/A

0DataRank · unranked

0 citations

Adrienne L. Lehnert, Aimee L. Kenoyer, Donald K. Hamlin, Andrew D. Ludwig, Alan F. Utria +9 more